{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:54:35Z","timestamp":1767135275573,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd001246","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2009,10,7]],"date-time":"2009-10-07T00:00:00Z","timestamp":1254873600000}}],"reference-count":77,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd001246.pub2","type":"journal-article","created":{"date-parts":[[2009,10,21]],"date-time":"2009-10-21T16:12:55Z","timestamp":1256141575000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Thienopyridine derivatives versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients"],"prefix":"10.1002","author":[{"given":"Cathie LM","family":"Sudlow","sequence":"first","affiliation":[{"name":"University of Edinburgh; Division of Clinical Neurosciences; Western General Hospital Crewe Road Edinburgh UK EH4 2XU"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Mason","sequence":"additional","affiliation":[{"name":"Maroondah Hospital; Davey Drive Ringwood East Melbourne Victoria Australia 3135"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James B","family":"Maurice","sequence":"additional","affiliation":[{"name":"University of Edinburgh; College of Medicine and Veterinary Medicine; The Chancellor's Building 49 Little France Crescent Edinburgh UK EH16 4SB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine J","family":"Wedderburn","sequence":"additional","affiliation":[{"name":"University of Edinburgh; College of Medicine and Veterinary Medicine; The Chancellor's Building 49 Little France Crescent Edinburgh UK EH16 4SB"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme J","family":"Hankey","sequence":"additional","affiliation":[{"name":"Royal Perth Hospital; Department of Neurology; Wellington Street Perth Western Australia Australia 6001"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,10,7]]},"reference":[{"issue":"22","key":"10.1002\/14651858.CD001246.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1001\/jama.289.22.2947","article-title":"Aspirin and ticlopidine for prevention of recurrent stroke in black patients. A randomised trial","volume":"289","author":"Gorelick","year":"2003","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)","volume":"348","author":"CAPRIE Steering Committee","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD001246.pub2-BIB0003|cit3","first-page":"42","article-title":"Ticlopidine for patients on short-term incidence of ischemic stroke with high glycocalicin plasma levels","volume":"107","author":"Lucia","year":"2000","journal-title":"Journal of Neural Transmission"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0004|cit4","first-page":"2255","article-title":"Effects of aspirin and ticlopidine on transient ischaemic attack","volume":"74","author":"Murakami","year":"1986","journal-title":"Sindan To Chiryo"},{"issue":"9","key":"10.1002\/14651858.CD001246.pub2-BIB0005|cit5","first-page":"950","article-title":"Effects of ticlopidine and aspirin on TIA - a twelve month, double blind comparative study","volume":"127","author":"Murakami","year":"1983","journal-title":"Igaku no Ayumi"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0007|cit6","first-page":"19","article-title":"L'etude japonaise de la ticlopidine dans les accidents ischemiques transitoires","volume":"April","author":"Tohgi","year":"1990","journal-title":"Maladies Cerebrovasculaires"},{"issue":"4","key":"10.1002\/14651858.CD001246.pub2-BIB0008|cit7","first-page":"19","article-title":"The Japanese ticlopidine study in transient ischaemic attacks","volume":"2","author":"Tohgi","year":"1990","journal-title":"Sang Thrombose Vaisseaux"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0009|cit8","first-page":"279","article-title":"The effect of ticlopidine on TIA compared with aspirin: a double-blind, twelve-month follow-up study","volume-title":"Ticlopidine: Quo Vadis?","volume":"15","author":"Tohgi","year":"1984"},{"issue":"1","key":"10.1002\/14651858.CD001246.pub2-BIB0006|cit9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2169\/internalmedicine1962.26.117","article-title":"The effect of ticlopidine on TIA compared with aspirin - a double-blind, twelve-month and open 24-month follow-up study","volume":"26","author":"Tohgi","year":"1987","journal-title":"Japanese Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD001246.pub2-BIB0010|cit10","first-page":"146","article-title":"A prospective randomized control study on ticlopidine with aspirin for the prevention of ischaemic cerebral stroke","volume":"13","author":"Li","year":"2000","journal-title":"Journal of Clinical Neurology"},{"issue":"5","key":"10.1002\/14651858.CD001246.pub2-BIB0011|cit11","first-page":"476","article-title":"A randomized trial comparing ticlopidine with aspirin for the prevention of ischaemic cerebral stroke","volume":"20","author":"Li","year":"1999","journal-title":"Acta Pharmacologica Sinica"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0012|cit12","first-page":"259","article-title":"Comparison of ticlopidine and aspirin in unstable angina","volume":"16 Suppl","author":"Sadowski","year":"1995","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0013|cit13","unstructured":"Schoop W Open randomised study comparing ticlopidine with acetylsalicylic acid in the prevention of contralateral thrombosis in patients initially presenting with unilateral thrombosis Guildford: Sanofi Winthrop (Sanofi internal report 001.6.174) 1983"},{"issue":"5","key":"10.1002\/14651858.CD001246.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0735-1097(01)01164-0","article-title":"Ticlopidine versus aspirin after myocardial infarction (STAMI) trial","volume":"37","author":"Scrutinio","year":"2001","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM198908243210804","article-title":"A randomised trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients","volume":"321","author":"Hass","year":"1989","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD001246.pub2-BIB0016|cit16","first-page":"55","article-title":"Analyses of controlled trial of prevention against ischaemic stroke with different agents and dosage for patients recovering from cerebral infarction","volume":"5","author":"Zhu","year":"2001","journal-title":"Modern Rehabilitation"},{"issue":"1","key":"10.1002\/14651858.CD001246.pub2-BIB0017|cit17","first-page":"1300","article-title":"Clinical evaluation of ticlopidine in the inhibition of platelet function: A multiclinic double-blind study in comparison with aspirin","volume":"46","author":"Abe","year":"1981","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1046\/j.1468-1331.1999.610057.x","article-title":"The effect of aspirin, ticlopidine and their low-dose combination on platelet aggregability in acute ischemic stroke: a short duration follow-up study","volume":"6","author":"Akyuz","year":"1999","journal-title":"European Journal of Neurology"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/030006058901700104","article-title":"Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents","volume":"17","author":"Apollonio","year":"1989","journal-title":"Journal of International Medical Research"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0020|cit20","first-page":"610","article-title":"Prevention of thromboembolism with ticlopidine shortly after valve repair or replacement with a bioprosthesis","volume":"7","author":"Aramendi","year":"1998","journal-title":"Journal of Heart Valve Disease"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0021|cit21","first-page":"33","article-title":"A randomised trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS study)","volume":"12","author":"Bergamasco","year":"1997","journal-title":"Functional Neurology"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jacc.2005.09.034","article-title":"Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination","volume":"47","author":"Cooke","year":"2006","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD001246.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00005344-200204000-00008","article-title":"Effects of combined therapy with clopidogrel and acetylsalicylic acid on platelet glycoprotein expression and aggregation","volume":"39","author":"Dorr","year":"2002","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00005344-199610000-00018","article-title":"Hemostaseologic and hematologic parameters with aspirin and ticlopidine treatment in patients with cerebrovascular disease: a cross-over study","volume":"28","author":"Droste","year":"1996","journal-title":"Journal of Cardiovascular Pharmacology"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/01616412.1996.11740450","article-title":"Asymptomatic circulating cerebral emboli and cerebral blood flow velocity under aspirin and ticlopidine in patients with cerebrovascular disease","volume":"18","author":"Droste","year":"1996","journal-title":"Neurological Research"},{"issue":"6","key":"10.1002\/14651858.CD001246.pub2-BIB0026|cit26","first-page":"954","article-title":"Differences in platelet aggregation in patients with cerebrovascular disease under ASA or ticlopidine","volume":"73","author":"Siemens","year":"1995","journal-title":"Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0027|cit27","first-page":"163","article-title":"Modified platelet aggregation test in patients on ASA and\/or clopidogrel","volume":"27","author":"Eder","year":"2007","journal-title":"Hamostaseologie"},{"issue":"5","key":"10.1002\/14651858.CD001246.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1080\/003655200750023705","article-title":"Gastroduodenal tolerance of 75 mg clopidogrel versus 325 mg aspirin in healthy volunteers. A gastroscopic study","volume":"35","author":"Fork","year":"2000","journal-title":"Scandinavian Journal of Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD001246.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09537105310001645960","article-title":"The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease","volume":"15","author":"Jagroop","year":"2004","journal-title":"Platelets"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0002-9149(03)00328-X","article-title":"Effects of coadministration of aspirin or clopidogrel on exercise testing in patients with heart failure receiving angiotensin-converting enzyme inhibitors","volume":"91","author":"Kindsvater","year":"2003","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD001246.pub2-BIB0031|cit31","first-page":"126","article-title":"The Kaohsiung Medical College Hospital Ticlopidine Study (KTS): a five-year prospective study to follow the outcome and complication of ticlopidine hydrochloride in Taiwanese","volume":"8","author":"Chen","year":"1999","journal-title":"Acta Neurologica Taiwanica"},{"issue":"3","key":"10.1002\/14651858.CD001246.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jtcvs.2004.03.007","article-title":"Clopidogrel did not inhibit platelet function early after coronary bypass surgery: a prospective randomized trial","volume":"128","author":"Lim","year":"2004","journal-title":"Journal of Thoracic & Cardiovascular Surgery"},{"issue":"3","key":"10.1002\/14651858.CD001246.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0149-2918(96)80029-4","article-title":"Efficacy of combination antiplatelet therapy and nicardipine for chronic cerebral infarction","volume":"18","author":"Nomura","year":"1996","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0034|cit34","first-page":"53","article-title":"Effect of ticlopidine and aspirin on plasma fibrinogen level","volume":"7 Suppl 4","author":"Ozalp","year":"1997","journal-title":"Cerebrovascular Diseases"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0035|cit35","first-page":"S119","article-title":"Effect of ticlopidine and aspirin on plasma fibrinogen level","volume":"4 Suppl 1","author":"Ozalp","year":"1997","journal-title":"European Journal of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD001246.pub2-BIB0036|cit36","first-page":"25","article-title":"Comparative efficacy of tiklid and aspirin in patients with unstable angina","volume":"73","author":"Rebrov","year":"2001","journal-title":"Terapevticheskii Arkhiv"},{"issue":"126","key":"10.1002\/14651858.CD001246.pub2-BIB0037|cit37","first-page":"214","article-title":"Antiaggregant treatment for cerebral ischemia: ticlopidine versus aspirin","volume":"24","author":"Rey","year":"1996","journal-title":"Revista de Neurologia"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1161\/01.CIR.97.11.1046","article-title":"Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation","volume":"97","author":"Rupprecht","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0039|cit39","first-page":"300","article-title":"Effect of aspirin and ticlopidine, alone or combined, on platelet aggregation in acute ischaemic stroke","volume":"2","author":"Singh","year":"1999","journal-title":"Journal of Internal Medicine of India"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0040|cit40","unstructured":"Uchiyama S Safety and efficacy of ticlopidine alone or with aspirin in patients with cerebral infarction or TIA Unpublished 1993"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0041|cit41","first-page":"37","article-title":"Aspirin vs ticlid and their combination in patients with acute myocardial infarction","volume":"78","author":"Vyshlov","year":"2000","journal-title":"Klinicheskaia Meditsina"},{"issue":"11","key":"10.1002\/14651858.CD001246.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1538-7836.2004.01017.x","article-title":"Randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and C-reactive protein following myocardial infarction: the CADET trial","volume":"2","author":"Woodward","year":"2004","journal-title":"Journal of Thrombosis & Haemostasis"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0043|cit43","unstructured":"Zucca R Farina M Basellini A Bonalumi FA Dellavedova M Evaluation of ASA and ticlopidine treatment to prevent carotid restenosis after carotid TEA. Preliminary report Proceedings of the 16th World Congress of the International Union of Angiology 1992 338"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0044|cit44","first-page":"49","article-title":"Effectiveness of unstable angina pectoris treatment by aggregation inhibitors ticlid and aspirin","volume":"76","author":"Bokarev","year":"1998","journal-title":"Klinicheskaia Meditsina"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1161\/CIRCULATIONAHA.108.801753","article-title":"Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial","volume":"119","author":"Massie","year":"2009","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/14017430410024324","article-title":"Unstable angina, stroke, myocardial infarction and death in aspirin non-responders. A prospective, randomized trial. The ASCET (ASpirin non-responsiveness and Clopidogrel Endpoint Trial) design","volume":"38","author":"Pettersen","year":"2004","journal-title":"Scandinavian Cardiovascular Journal"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","author":"Antiplatelet Trialists' Collaboration","year":"1994","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","author":"Antithrombotic Trialists' Collaboration","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/archinte.159.21.2524","article-title":"Thrombotic thrombocytopenic purpura associated with ticlopidine in the setting of coronary artery stents and stroke prevention","volume":"159","author":"Bennett","year":"1999","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/01.CIR.102.6.624","article-title":"Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting","volume":"102","author":"Bertrand","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0051|cit51","unstructured":"British National Formulary http:\/\/www.bnf.org\/bnf\/ September 2008"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1161\/01.CIR.0000163561.90680.1C","article-title":"Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: the Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial","volume":"111","author":"Markus","year":"2005","journal-title":"Circulation"},{"issue":"3","key":"10.1002\/14651858.CD001246.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa042087","article-title":"Clopidogrel versus aspirin and esomeprazole to prevent recurrent ulcer bleeding","volume":"352","author":"Chan","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"The ESPRIT Study Group","year":"2006","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European secondary prevention study 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"Journal of Neurological Sciences"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","article-title":"Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial","volume":"6","author":"Kennedy","year":"2007","journal-title":"Lancet Neurology"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1527-3466.1993.tb00275.x","article-title":"Clopidogrel, a novel antiplatelet and antithrombotic agent","volume":"11","author":"Hebert","year":"1993","journal-title":"Cardiovascular Drug Reviews"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1001\/jama.2009.261","article-title":"Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome","volume":"301","author":"Ho","year":"2009","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1572-0241.2006.01062.x","article-title":"Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplatelet agents, and anticoagulants","volume":"102","author":"Lanas","year":"2007","journal-title":"American Journal of Gastroenterology"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"364","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2165\/00003495-199040020-00006","article-title":"Ticlopidine: an updated review of its pharmacology and therapeutic use in platelet-dependent disorders","volume":"40","author":"McTavish","year":"1990","journal-title":"Drugs"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4613-8306-2_9","article-title":"An analysis of the side effects of ticlopidine.","volume-title":"Ticlopidine, Platelets and Vascular Disease","author":"Moloney","year":"1993"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.CIR.101.6.590","article-title":"A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents","volume":"101","author":"M\u00fcller","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0065|cit65","unstructured":"National Institute for Health and Clinical Excellence Technology Appraisal 90: Clopidogrel and modified-release dipyridamole in the prevention of occlusive vascular events http:\/\/www.nice.org.uk\/nicemedia\/pdf\/TA090guidance.pdf 2005"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0165-6147(89)80010-0","article-title":"Aspirin and human platelets: from clinical trials to acetylation of cyclooxygenase and back","volume":"10","author":"Patrono","year":"1989","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","article-title":"Aspirin as an antiplatelet drug","volume":"330","author":"Patrono","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","article-title":"Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke","volume":"358","author":"Sacco","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMe0806806","article-title":"Stroke prevention - insights from incoherence","volume":"359","author":"Kent","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0070|cit70","volume-title":"National Clinical Guidelines for Stroke","author":"Royal College of Physicians Intercollegiate Stroke Working Party","year":"2008"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(05)67641-6","article-title":"Something old, something new: beta blockers and clopidogrel in acute myocardial infarction","volume":"366","author":"Sabatine","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0072|cit72","unstructured":"Scottish Intercollegiate Guidelines Network Guideline 108. Management of patients with stroke or TIA: assessment, investigation, immediate management and secondary prevention http:\/\/www.sign.ac.uk\/pdf\/sign108.pdf 2008"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1001\/jama.281.9.806","article-title":"Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting","volume":"281","author":"Steinhubl","year":"1999","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ajh.2830500203","article-title":"Increasing mortality from thrombotic thrombocytopenic purpura in the United States: analysis of national mortality data, 1968-1991","volume":"50","author":"Torok","year":"1995","journal-title":"American Journal of Haematology"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD001246.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/01.STR.0000109253.66918.5E","article-title":"Clopidogrel-associated TTP: an update of pharmacovigilance efforts conducted by independent researchers, pharmaceutical suppliers, and the Food and Drug Administration","volume":"35","author":"Zakarija","year":"2004","journal-title":"Stroke"},{"issue":"1","key":"10.1002\/14651858.CD001246.pub2-BIB0077|cit77","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001246","article-title":"Thienopyridine derivatives (ticlopidine, clopidogrel) versus aspirin for preventing stroke and other serious vascular events in high vascular risk patients","author":"Hankey","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD001246.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T17:01:08Z","timestamp":1628528468000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD001246.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Stroke Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2009,10,7]]},"references-count":77,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd001246.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10,7]]}}}